Ryan Schmidt
Investor Relations, Clover Health
Replay available
Clover Health Investments, Corp. (NASDAQ: CLOV) Q1 2025 earnings conference call, held 2025-05-06. Replay captured from the company's public earnings webcast.

Investor Relations, Clover Health
Chief Executive Officer, Clover Health
Chief Financial Officer, Clover Health
Analyst, UBS
Analyst, Craig Hallam Capital
Analyst, Canaccord Genuity
Ladies and gentlemen, good afternoon and welcome to the Clover Health first quarter 2025 earnings conference call. At this time, all participants are in a listen-only mode. A question and answer session will follow the prepared remarks. At that time, if you wish to ask a question, please press star 1 on your telephone keypad. As a reminder, today's call is being recorded. I would now like to turn the call over to Ryan Schmidt, investor relations for Clover Health. Please go ahead. Good afternoon, everyone. Joining me on our call today to discuss the company's first quarter 2025 results are Andrew Toy, Clover Health's Chief Executive Officer, and Peter Kuypers, the company's Chief Financial Officer. You can find today's press release in the accompanying supplemental slides, as well as the company's most recent investor deck in the investor events and presentation section of our website at investors.cloverhealth.com. This webcast is being recorded and a replay will be available in the investor relations section of the Clover Health website. I'd also like to caution you that we may make forward-looking statements during today's call that are subject to risks and uncertainties, including expectations about future performance. Factors that may cause actual results to differ materially from expectations are detailed in our SEC filings, including in the risk factors section of our most recent annual report on Form 10-K and other SEC filings. Information about non-GAAP financial measures referenced, including our reconciliation of those measures to GAAP measures, can be found in the earnings materials available on our website. With that, I'll now turn the call over to Andrew. All right, everyone. Thanks for joining us today. I'm excited to dive into our first quarter 2025 re...